The present study demonstrated that NR2F6 can promote the proliferation of lung cancer cells at the cellular level and further explored its molecular mechanism, both of which are of important clinical significance for improving the prognosis of lung cancer and identifying new molecular targeted drugs. Here, NR2F6 is linked to lung carcinoma.